Skip to main content
Fig. 4 | Journal of Experimental & Clinical Cancer Research

Fig. 4

From: CXCL12/CXCR4 promotes inflammation-driven colorectal cancer progression through activation of RhoA signaling by sponging miR-133a-3p

Fig. 4

CXCR4 exacerbated CRC progression by increasing inflammatory cytokines and recruiting immune suppressive cells. a ELISA was performed to examine the levels of cytokine IL-1, IL-6 and TNFα (n = 5 for each group). b The levels of IL-1β, IL-6, p-JAK2/JAK2, p-STAT3/STAT3 and COX2 were determined by Western blot assay. Bar graphs indicated the relative levels of these proteins normalized to β-actin. *P < 0.05 vs. WT mice. #P < 0.05 vs. CXCR4+/− mice. c, d The percentages of gated CD4+, CD8+ T-cells, CD11b+F4/80+ macrophages, CD11b+Ly6C+, CD11b+Ly6G+ MDSCs immune cells in the blood and colonic tissues of AOM/DSS treated mice were subjected to flow cytometry analysis (n = 5 for each group). e Representative images were shown to indicate the expression of F4/80, CD4+, CD8+ T-cells in different groups (n = 5) determined by immunohistochemistry assay (400 ×)

Back to article page